Arch Therapeutics, Inc. – Ticker: ARTH

Small Cap Spotlight Podcast

Arch Therapeutics, Inc. – Ticker: ARTH

Play Episode Pause Episode

Mute/Unmute Episode Rewind 10 Seconds 1x Fast Forward 30 seconds

00:00 / 19:33

RSS Feed

Share

Link

Embed

Arch Therapeutics, Inc. is a medical device company developing a novel approach to stop bleeding
(hemostasis) and control leaking (sealant) during surgery and trauma care. Arch is developing products
based on an innovative self-assembling peptide technology platform to make surgery and interventional
care faster and safer for patients. Arch’s flagship development stage product candidate, known as the
AC5 Surgical Hemostatic Device, is being designed to achieve hemostasis in minimally invasive and open
surgical procedures.

Web Site: ArchTherapeutics.com